B-cell depletion in rheumatoid arthritis: the prospect of long-term benefit

By Leandro Maria J   Cambridge Geraldine   Edwards Jonathan CW  

Future Rheumatology, Vol. 1, Iss. 4, 2006-08 ,pp. : 493-499

Future Medicine

Access to resources Recommend Favorite

Improvement of refractory rheumatoid arthritis after depletion of B cells

By Kneitz C   Wilhelm M   Tony H-P  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 2, 2004-03 ,pp. : 82-86

Informa Healthcare

Access to resources Recommend Favorite

Homozygous FCGR3A-158F mutation is associated with delayed B-cell depletion following rituximab but with preserved efficacy in a patient with refractory lupus nephritis

By Seret Guillaume   Hanrotel Catherine   Bendaoud Boutahar   Le Meur Yannick   Renaudineau Yves  

Clinical Kidney Journal, Vol. 6, Iss. 1, 2013-02 ,pp. : 74-76

Oxford University Press

Access to resources Recommend Favorite

Induced psoriasis after rituximab therapy for rheumatoid arthritis: a case report and review of the literature

By Guidelli G.   Fioravanti A.   Rubegni P.   Feci L.  

Rheumatology International, Vol. 33, Iss. 11, 2013-11 ,pp. : 2927-2930

Springer Publishing Company

Access to resources Recommend Favorite

Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis

By Kerekes György   Soltész Pál   Dér Henriett   Veres Katalin   Szabó Zoltán   Végvári Anikó   Szegedi Gyula   Shoenfeld Yehuda   Szekanecz Zoltán  

Clinical Rheumatology, Vol. 28, Iss. 6, 2009-06 ,pp. : 705-710

Springer Publishing Company

Access to resources Recommend Favorite